Summary. Hypothalamic and autonomic nervous regulation of carbohydrate and amino acid metabolism in the liver and of lipid metabolism in adipose tissues is described. The direct neural mechanism underlying this regulation has been evaluated. Electrical stimulation of the ventromedial hypothalamic nucleus (VMH)-splanchnic nerve system causes glycogenolysis in the liver by rapid activation of glycogen phosphorylase, whereas electrical stimulation of the lateral hypothalamic nucleus (LH)-vagus nerve system promotes glycogenesis in the Iiver by activation of glycogen synthetase, through direct neural and neural-hormonal mechanisms. Studies on chemical coding of the hypothalamic neurones have revealed that norepinephrine-sensitive neurones in the VMH and acetylcholine-sensitive neurones in the LH are specifically involved in the regulation of liver phosphorylase and glycogen synthetase, respectively. Acetylcholine-sensitive neurones of the LH were also found to be concerned in regulation of hepatic tyrosine aminotransferase activity, through intermediation of the cholinergic system in the LH-vagal pathway. Finally, it has been shown that the VMH acts as a regulatory centre for lipolysis in adipose tissues by modulating activation of the sympathetic nervous system. In addition, stimulation of the VMH enhanced lipogenesis in brown adipose tissue preferentially, probably through a mechanism mediated by sympathetic innervation of this tissue. The latter finding suggests that both the breakdown and resynthesis of triglycetides in brown adipose tissue, but not in white adipose tissue, are accelerated by stimulation of the VMH.
Since the classical observation by Bernard in the 1850's that puncture (piqfire) of the floor of the fourth ventricle results in the appearance of transient glucosuria, the CNS has been implicated in the control of certain metabolic processes, mainly through neuroendocrine or hormonal regulation. However, whether this control is purely neural is conjectural, and direct proof for this postulation has only recently been obtained [1, 2] . Although neural and hormonal regulation of metabolism are interrelated and act in coordination, neural regulation generally is fine and rapid, being suitable for emergency situations, whereas hormonal regulation is stable and suitable for supplementing and fortifying neural regulation.
Of central neural structures, the hypothalamus is regarded as an important integrative station for neural and hormonal regulation of peripheral metabolism. The hypothalamus is believed to be the highest autonomic centre that coordinates visceral activities in response to the ever-changing conditions of the internal and external environment, and it modulates hormonal secretion both through production of hypothalamic-releasing and inhibiting hormones and by sending neural signals to the endocrine organs.
In the hypothalamus there are groups of nerve cells or nuclei, which can be roughly divided structur-0012-186X/81/0020/0343 /$02.80 VMH and LH in metabolic regulation also seem to be reciprocal, particularly in the regulation of carbohydrate metabolism in the liver [7, 8] . The reciprocal regulation parallels that of the sympathetic and parasympathetic nerves, as discussed later. Thus, the axons emerging from the VMH neurones are presumed to go through the midbrain, pons, medulla and the spinal cord to reach the intermediolateral cell column by polysynaptic pathways, which then communicate with the splanchnic nerves and the abdominal sympathetic nerves at the level of the thoracic cord. Similarly some of the LH neurones may connect with the vagus nerves at the level of the dorsal motor nucleus of the vagus of the medulla and form the LH-vagal circuit. These VMH-splanchnic and LH-vagal pathways then innervate various internal organs, thus mediating neural and neural-hormonal influences upon metabolic processes in the viscera ( ally and functionally into the medial and the lateral hypothalamic areas at the boundary of the fornix. Although the medial hypothalamus actually contains several nuclei, including the anterior hypothalamic nucleus, ventromedial hypothalamic nucleus, dorsomedial hypothalamic nucleus, posterior hypothalamic nucleus, and dorsal and ventral premamillary nuclei, the ventromedial hypothalamic nucleus (VMH) has the central function. The lateral hypothalamus is composed of the lateral hypothalarnic nucleus (LH), the cells of which are diffusely scattered amongst the upward and downward nerve fibres. The VMH and LH are considered to act reciprocally in several regulatory functions. For regulation of food intake, for instance, the VMH is believed to act as the satiety centre while the LH acts as the feeding centre [3, 4] . With respect to regulatory influences on autonomic nerves, the VMH belongs to the sympathetic system and the LH to the parasympathetic system [5, 6] . In general, the functions of the
Hypothalamo-Hepatic Axis in the Control of Carbohydrate Metabolism
Evidence for reciprocal functions of the VMH and LH in the regulation of hepatic carbohydrate metabolism was obtained from studies of changes in liver glycogen metabolism after electrical stimulation of these hypothalamic nuclei [9] : stimulation of the VMH caused glycogenolysis in the liver, as indicated by the rapid rise in circulating glucose level and from the marked decrease in liver glycogen content with prolonged stimulation. Electrical stimulation of the LH, on the other hand, seemed to result in glycogen synthesis in the liver, since it caused a slight fall in blood glucose level and an insignificant increase in liver glycogen content with prolonged stimulation.
This work was later extended by analyzing changes in the activities of key hepatic enzymes involved in glycogen breakdown and synthesis [7, 10] , i.e., glycogen phosphorylase (EC 2.4.1.1)and glycogen synthetase (EC 2.4.1.11). Phosphorylase and synthetase exist in the liver in two interconvertible forms; phosphorylase a and synthetase I are physiologically active, while phosphorylase b and synthetase D are essentially inactive in vivo. Therefore, the levels of phosphorylase a and synthetase Iin the liver can be regarded as reflecting the rate of breakdown and synthesis of glycogen in the liver, respectively.
When the VMH of rats was stimulated electrically, the activity of liver phosphorylase a increased rapidly and markedly, reaching a maximum activity of about 3-fold over unstimulated activity within 30 s [10] . This maximum level of phosphorylase a was then maintained for 5 min of stimulation. The activity of synthetase /, on the other hand, did not change significantly on stimulation of the VMH. Conversely, on electrical stimulation of the LH, an increase in the level of liver synthetase I was observed [10] . A significant increase could be detected after 10-30 min of stimulation, and the level had increased about 2-fold after 60 min. Electrical stimulation of the LH, however, caused little change in the activity of liver phosphorylase a.
These results indicate that electrical stimulation of the VMH causes glycogenolysis in the liver by rapid activation Of glycogen phosphorylase, leading to a prompt rise in blood glucose, while stimulation of the LH promotes glycogen synthesis in the liver by activation of glycogen synthetase and leads to a rather slow and small decrease of blood glucose.
Since the above results were obtained with electrical stimulation, they raised the question of whether the hypothalamic effects on hepatic glycogen metabolism stem from activation of specific neurones in the hypothalamic nuclei or from activation of fibres that are merely passing through these areas. The hypothalamic nuclei possibly consist of a collection of different types of neurones. By employing a microinjection technique, it is possible to achieve chemical stimulation of a specific subset of neurones in the VMH and LH with different neurotransmitters, and to study "chemical coding" of the hypothalamic neurones in metabolic control [11] [12] [13] [14] .
As described above, the VMH is a sympathetic centre for controlling glycogen breakdown in the liver by increasing phosphorylase a activity. To see what types of neurones of the VMH are concerned in regulation of hepatic glycogenolysis, the effect of chemical stimulation of the VMH on liver phosphorylase was studied [13, 14] . Selective stimulation of the VMH neurones with norepinephrine resulted in an increase of liver phosphorylase a. Stimulation with other neurotransmitters, including dopamine, serotonin, acetylcholine, and 7-aminobutyric acid (GABA) had no effect on phosphorylase a activity. The response of liver phosphorylase to noradrenergic stimulation of the VMH was very rapid, like that occurring after electrical stimulation, and attained a maximum within 1 min of the locaI application of norepinephrine. After 10 min it returned to the level of the control group similarly treated with saline. The maximal effect was obtained with a dose of norepinephrine of 5 x 10 -1~ moles or more, a concentration that is well within the physiological range. The increase in liver phosphorylase a activity after noradrenergic stimulation of the VMH was due to activation of the enzyme, i.e., to conversion of phosphorylase b into the a form, and not to new synthesis of enzyme protein.
The activation of liver phosphorylase after noradrenergic stimulation of the VMH was suppressed by previous treatment of the VMH neurones with local propranolol, but not with phentolamine [14] . These results suggest that norepinephrine--sensitive neurones in the VMH are specifically involved in regulation of phosphorylase activity in the liver and that the effect of norepinephrine is linked to /3-adrenergic receptors in the hypothalamus. In addition, activation of liver phosphorylase by noradrenergic stimulation of the VMH was also blocked by previous IP injection of hexamethonium, a ganglionic blocking agent. This finding may be explained by supposing that the effect of norepinephrine-sensitive neurones of the VMH is mediated by peripheral sympathetic nerves. There is evidence that the splanchnic nerves exert direct neural control over liver phosphorylase [1, 15, 16] , as discussed later. Rosenberg and DiStefano [17] and Ezdinli et al. [18] have also shown that the hyperglycaemia induced by systemic administration of epinephrine is inhibited by section of the medulla or the spinal cord. However, the influence of glycogenolytic hormones, particularly pancreatic hormones, on phosphorylase activation after hypothalamic stimulation has to be taken into account.
To characterize the LH neurones concerned with regulation of hepatic glycogen synthesis, the effect of chemical stimulation of the LH on liver synthetase was studied [11, 12] . Cholinergic stimulation of the LH by microinjection of acetylcholine or carbachol resulted in a marked increase in synthetase Iactivity. Since the total activity of synthetase (/plus D forms) did not change appreciably, the ratio of syn~thetase I to total synthetase must have increased remarkably; i.e., acetylcholine caused activation of the enzyme. The lowest effective dose of acetylcholine was 5 • 10 -1~ moles, and the optimum dose was 5 x 10 -9 moles. Similar application of other neurotransmitters, including serotonin, norepinephrine, dopamine, and GABA, did not alter liver synthetase activity appreciably.
The effect of hypothalamic cholinergic stimulation on liver synthetase was blocked by previous local treatment of the LH neurones with anticholinergic agents, such as atropine and scopolamine [12] . Thus, acetylcholine injected into the LH seems to act through cholinergic (probably muscarinic) transmission in the LH. The fairly specific activation of liver synthetase, produced by cholinergic stimulation of the LH, and its blockade by central administration of anticholinergic agents strongly suggest that: acetylcholine-sensitive neurones in the LH are involved in regulation of glycogen synthesis in the liver.
The activation of liver synthetase induced by cholinergic stimulation of the LH was also blocked completely by previous IP injection of N-methylatropine [12] , an anticholinergic agent that does not readily penetrate the blood-brain barrier. This latter observation tends to confirm the idea that the effect of acetylcholine-sensitive neurones of the LH may be mediated by peripheral cholinergic nerves. As discussed later, the vagus nerves exert direct neural effects in regulation of liver glycogen synthesis [19, 20] . Hence, the neural regulation of liver glycogen synthesis appears to be mediated centrally as well as peripherally by the cholinergic system.
The reciprocity of the VMH and LH has also been demonstrated in regulation of hepatic gluconeogenesis and glycolysis [21] . Electrical stimulation of the VMH caused an increase in the activity of phosphoenolpyruvate carboxykinase (PEPCK) (EC 4.1.1.32), a key gluconeogenic enzyme, and a marked suppression of pyruvate kinase (PK) (EC 2.7.1.40), a key glycolytic enzyme, in rat liver. Stimulation of the LH, on the other hand, resulted in a decrease in PEPCK activity but did not alter PK activity. The maximum responses of these enzymes were obtained after 4 h of intermittent hypothalamic stimulation. These results suggest that the gluconeogenic process in the liver is enhanced by stimulation of the VMH and suppressed by stimulation of the LH, while the glycolytic process is inhibited by VMH stimulation. The stimulatory effect of the VMH on hepatic gluconeogenesis, presumably caused by the synergistic effects of increased adrenergic nervous activity and increased output of glucagon, is thus complementary to its glycogenolytic effect on the liver in producing hyperglycaemia. However, the gluconeogenic responses to VMH stimulation are rather slow reactions, unlike the glycogenolytic responses, which occur very rapidly [9, 10, 22] , and so are probably less important than the latter in an emergency.
Neural-Metabolic Interaction in the Liver
Both the sympathetic and parasympathetic nervous systems are important modulators of hepatic metabolism [2] . Nerves innervating the liver include sympathetic, parasympathetic and afferent components. The sympathetic fibres are derived from the splanchnic nerves and their postganglionic fibres originate in the celiac ganglia and plexus. The parasympathetic fibres are from the vagus nerves, and the ganglion cells concerned are located close to the liver. The liver cells are directly innervated. Electron microscopic studies [23, 24] have revealed nerve terminals making direct contact with hepatocytes. These terminals are commonly embedded in indentations in parenchymal cells and contain various numbers of both clear and dense-cored vesicles. Therefore, it appears that liver cells are subjected to direct neural control through both the sympathetic and parasympathetic nerves.
Afferent innervation of the liver may also be important for the sensory function of the liver [25] . Particularly because the liver is intimately involved in the metabolism and disposal of nutrients, metabolic receptors in the liver are presumed to inform the brain about the caloric content of ingested foodstuffs. It has been assumed, for instance, that afferent impulses from hypothetical hepatic glucoreceptors ascend through afferent fibres of the vagus [26] [27] [28] , and that this information gets at least to the level of the hypothalamus [29] [30] [31] . Thus, the autonomic centre of the hypothalamus probably receives a constant afferent influx of glucose-related signals from the liver, which may interact with hypothalamic mechanisms controlling centrifugal influences upon hepatic carbohydrate metabolism and provide a feedback-control of glucose homeostasis.
The first evidence that hepatic glycogenolysis is under the direct control of hepatic sympathetic innervation was obtained in 1965, when we demonstrated rapid rises in the activities of hepatic glycogenolytic enzymes (phosphorylase and glucose-6-phosphatase (EC 3.1.3.9)) and concomitant decreases in the liver glycogen content after electrical stimulation of the peripheral end of the left splanchnic nerves [32] . Subsequently, the roles of the peripheral autonomic nerves in regulating glycogen-metabolizing enzymes have been studied extensively [1, 15] . The increase in phosphorylase and glucose-6-phosphatase activities in response to splanchnic-nerve stimulation reached a maximum within 30 s after the onset of stimulation, and the half-time of the increase was approximately 14 s. These effects of splanchnic-nerve stimulation were completely counteracted by simultaneous stimulation of the vagus nerves, although vagal stimulation alone had little effect on the enzymes. The increase in phosphorylase activity caused by splanchnic-nerve stimulation was due to activation of the enzyme, i. e., conversion of the inactive phosphorylase b to the active a form, because the total amount of phosphorylase (b plus a forms) was not altered appreciably by nerve stimulation. In the resting state, about a quarter of the total phosphorylase in the liver was active (a form). The amount of the active form increased to three-quarters of the total after 30-s stimulation of the splanchnic nerves, but was unchanged during vagal stimulation.
The activation of phosphorylase induced by splanchnic-nerve stimulation was not eliminated by adrenalectomy or pancreatectomy of the animals, indicating that epinephrine and glucagon are not necessary for the rapid activation of liver phosphorylase by splanchnic-nerve stimulation [1, 32] . These findings show that the responses of glycogenolytic enzymes are directly dependent upon the integrity of hepatic sympathetic innervation. These enzymatic responses provide a satisfactory explanation for the hyperglycaemic and glycogenolytic effects of splanchnic-nerve stimulation in adrenalectomized and pancreatectomized animals of various species [33] [34] [35] [36] [37] . Edwards [33] [34] [35] showed that the hyperglycaemic response to splanchnic-nerve stimulation persisted after adrenalectomy or pancreatectomy, but that it was greatly reduced by section of the hepatic nerves.
The hepatic phosphorylase responded more rapidly to stimulation via sympathetic innervation than to intraportal administration of catecholamines; the latter effect was blocked by a fl-adrenergic blocking agent, whereas the former effect was not [15] . The mechanism of phosphorylase activation by the splanchnic nerves was compared with those by catecholamines and glucagon [16] . The mechanism of phosphorylase activation by catecholamines via a/3-adrenergic receptor and by glucagon has been well established: A cyclic AMP-initiated cascade reaction leads to activation of a protein kinase, phosphorylase kinase (EC 2.7.1.38), and phosphorylase (Fig. 2) . In contrast, splanchnic-nerve stimulation was found to cause a rapid increase in the phosphorylase a content without increase in the levels of cyclic AMP, cyclic AMP-dependent protein kinase, and phosphorylase kinase [16] . These results indicate that the activation of hepatic phosphorylase after splanchnic-nerve stimulation, unlike that induced by the/3-adrenergic action of catecholamines and by glucagon, is not mediated by cyclic AMP and subsequent activations of protein kinase and phosphorylase kinase. Instead, the effect of splanchnic-nerve stimulation may be mediated by an a-adrenergic action of norepinephrine released in nerve terminals. This idea is supported by recent reports of Seydoux et al. [37] and Proost et al. [38] that neurally induced glucose output and phosphorylase activation was significantly inhibited by the a-adrenergic blocking agent phentolamine. Recent evidence has suggested that interaction of catecholamines (a-agonists) with the aadrenergic receptor causes a mobilization of Ca 2+ ions from mitochondria and other intracellular stores in liver cells. Thus, the mobilization of internal Ca 2+ and an increase in cytosolic Ca 2+ ion concentration are the major mechanisms of the a-adrenergic receptor system (for reviews, see [39, 40] ).
In our experiments shown in Figure 3 , however, activation of liver phosphorylase produced by splanchnic-nerve stimulation was not prevented by intraportal infusion of phentolamine, nor by previous IP injection of the potent fl-adrenergic blocking agent carteolol [41] at a dose that effectively suppressed the norepinephrine effect, or with both antagonists together. Nonetheless, the phosphorylaseactivating effect of nerve stimulation was completely blocked by the infusion of Diltiazem and Verapamil, Ca2+-antagonistic drugs that restrict calcium influx across the cell membrane (Fig. 4) . These findings suggest that the influx of extracellular Ca 2+, rather than mobilization of intracellular Ca 2+, is tightly coupled with nerve stimulation. In addition, the effect of splanchnic-nerve stimulation was also blocked by intraportal infusion of indomethacin (data not shown), implicating the involvement of prostaglandins in its mechanism.
Whether the a-receptor is involved or not in the mechanism by which splanchnic-nerve stimulation can activate liver phosphorylase, it may be agreed that the primary intracellular signal is a rise in cytosolic Ca 2+. The cytosolic Ca 2+ ions lead to the stimulation of phosphorylase kinase [16, 42] in a manner independent of cyclic AMP (see Fig. 2 ), but presumably in a manner analogous to that found recently for skeletal muscle phosphorylase kinase: as shown by Cohen et al. [43] , besides the known regulatory (a and/3) and catalytic (Y) subunits of rabbit skeletal muscle phosphorylase kinase, there is a fourth calcium-binding subunit (6-subunit), which is very similar or identical to the Ca2+-dependent modulator protein (calmodulin); binding of Ca 2+ to the 6-subunit is thought to result in stronger interaction of this subunit with one of the regulatory subunits (a or/3) thereby relieving inhibition on the catalytic (7) subunit.
Another possible explanation for the rise in phosphorylase a activity after splanchnic-nerve stimulation is that it may be due to inactivation of phosphorylase phosphatase (EC 3.1.3.17), presumably mediated by some unknown factor other than norepinephrine or Ca 2+ ions [16] . Phosphorylase phosphatase is known to counteract the activation of phosphorylase by phosphorylase kinase, and hence regulation of this enzyme is another likely point of control of phosphorylase activity (see Fig. 2 ). In connection with this possibility, we have isolated a factor from rabbit liver that can inactivate liver phosphorylase phosphatase, and by purification, this factor (named inactivating factor) has been identified as glutathione (GSSG) [44] . Incubation of the highly purified catalytic subunit of phosphorylase phosphatase (mol. wt., 3.3 • 104) with the isolated inactivating factor or GSSG converted the enzyme to a stable, less active form. Homogeneous phosphorylase phosphatase was found to contain two sulfhydryl groups per mole of catalytic subunit, one of which reacted with GSSG to form a mixed disulfide, thereby inactivating the enzyme [45] . Injection of GSSG into the portal vein of rabbits caused a rapid increase in phosphorylase a activity in the liver [44] . Thus it seems likely that GSSG participates in regulation of phosphorylase activity in vivo, by inactivating phosphorylase phosphatase in the liver. However, to date there is no evidence that GSSG is involved in mediation of phosphorylase activation after splanchnic-nerve stimulation.
Besides the role of the sympathetic nerves in control of phosphorylase activity and glycogenolysis, the role of the parasympathetic nerves in regulating glycogen synthetase and glycogen synthesis in the liver has also been elucidated [19, 20, 46] . The activity of liver synthetase was greatly increased by electrical stimulation of the peripheral end of the vagus nerves, but it was slightly decreased by splanchnic-nerve stimulation. The increase in enzymatic activity on vagal stimulation attained nearly a maximum within 10 min, and was shown to be due to conversion of the inactive form of the enzyme (D) to the active form (I). The effect of vagal stimulation on synthetase was not eliminated by previous pancreatectomy, indicating that the effect was not a secondary effect mediated by insulin. However, the effect was completely counteracted by simultaneous stimulation of the splanchnic nerves [20, 46] .
The activation of synthetase induced by vagal stimulation actually reflects an increased rate of glycogen synthesis in the liver [19] . On vagal stimulation, the rate of incorporation of radioactive glucose into liver glycogen in vivo was markedly enhanced; on splanchnic-nerve stimulation, the opposite effect was observed. The possibility that the increased rate of glycogen synthesis in response to vagal stimulation might be mediated indirectly by release of insulin from the pancreas was investigated by repeating the experiment on pancreatectomized animals. In these animals, a pronounced rise in glucose incorporation occurred on vagal stimulation, but the increase was somewhat less than that in intact animals. This suggests that the effect of vagal stimulation in increasing the rate of glycogen synthesis can be due mainly, if not entirely, to direct neural control. Further evidence for the parasympathetic nervous regulation of liver glycogen synthesis is that acetylcholine can stimulate glycogen synthetase in isolated, perfused rat liver [47] and in isolated hepatocytes [48] . Acute vagotomy in rats diminishes the rate of hepatic glycogen deposition after glucose load [49] . Therefore, the mediator for the parasympathetic nervous regulation of liver glycogen synthesis is probably acetylcholine.
In the light of these observations, it is clear that glycogen synthesis in the liver is enhanced by the direct action of the parasympathetic nerves through activation of glycogen synthetase, while glycogenolysis in the liver is stimulated by the sympathetic nerves through activation of phosphorylase and glucose-6-phosphatase. Furthermore, the above findings, together with the demonstration of hypothalamic control of liver glycogen metabolism discussed earlier, suggest that a cholinergic component in the LHvagal pathway mediates the neural regulation of glycogen synthesis in the liver, and that a noradrenergic component in the VMH-splanchnic nerve pathway is an opposing neural regulatory system for controlling glycogen breakdown and glucose output by the liver.
Neural-Hormonal Background Involved in Hypothalamic Control
Hepatic glycogenolysis may be regarded as an emergency reaction to meet the extra metabolic requirements of the tissues during stress, and it is not surprising, therefore, that the hypothalamus and the sympathetic nervous system exert a prominent role in this process. There are at least three separate mechanisms by which the sympathetic nervous system can activate hepatic glycogenolysis and rapidly supply the circulating blood with glucose: first, directly via the hepatic innervation; second, by the release of epinephrine from the adrenal medulla; and third, by the release of glucagon from the pancreatic islets. All three mechanisms are presumed to be integrated in the hypothalamus and to act in coordination (see Fig. 1 ).
Conversely to glycogenolysis, hepatic glycogen synthesis is a reaction for energy storage, and the process can be stimulated by mechanisms involving the direct action of hepatic parasympathetic nerves and neural stimulation of the release of insulin from the pancreas, both of which are also under the integrative control of the hypothalamus. Thus, the hypothalamic control of hepatic glycogenolysis and glycogen synthesis mentioned in the preceding section appears to be exerted both by neural messages transmitted from the hypothalamus to the liver via the autonomic nerves, and by hormonal messages intervening between the nerves and the liver.
It is well known that hypothalamic and sympathetic excitation causes the liberation of epinephrine from the adrenal medulla. There is now abundant evidence to show that autonomic innervation of the pancreatic islets modulates the secretion of both glucagon and insulin (for reviews, see [50, 51] ). Secretion of glucagon from the pancreatic A-cells is enhanced by electrical stimulation of the splanchnic sympathetic nerves, while the secretion of insulin from the pancreatic B-cells is inhibited by splanchnic-nerve stimulation and enhanced by stimulation of the vagal parasympathetic nerves. Sympathetic and parasympathetic influences via the hypothalamus can also affect the endocrine pancreas. Electrical stimulation of the VMH causes a rapid rise in plasma glucagon [22, 52] . Conversely, lesions of the VMH lead to an acute [53] as well as a chronic [54] [55] [56] [57] increase in the circulating level of insulin. The increased secretion of insulin may result from increased tone of the parasympathetic nervous system due to VMH lesions, since the VMH is the presumed hypothalamic sympathetic centre [2, 5, 6] and its destruction may lead to relative predominance of the other branch of the autonomic nervous system. Indeed, hyperinsulinaemia induced by VMH lesions has been shown to be reversed by subdiaphragmatic vagotomy [53, 58] . Electrical stimulation of the LH, on the other hand, fails to increase insulin secretion or change the plasma glucagon concentration [10, 52] . Recent studies [52, 59] on chemical stimulation of the hypothalamus have revealed further characteristics of hypothalamic neurones concerned in regulation of glucagon and insulin secretion. Microinjection of norepinephrine [59] or epinephrine [52] into the VMH was shown to induce secretion of both glucagon and insulin, while microinjection of acetylcholine [52] , probably through activation of nicotinic receptors in the VMH, caused selective release of glucagon. On the other hand, chemical stimulation of the LH with norepinephrine [59] or epinephrine [52] could induce a preferential rise in plasma insulin level without a significant change in the glucagon level. Microinjection of dopamine, serotonin, and GABA into the VMH or the LH was without effect [52] .
Frohman and Bernardis [22] analyzed the neuralhormonal mechanisms of hypothalamic control of glucose metabolism. In anaesthetized rats they observed a rapid rise in the plasma glucose level with a peak at 10-15 min after VMH stimulation, but not after LH stimulation. The role of the adrenal and the pancreas in this hyperglycaemic response was studied. Adrenalectomy did not inhibit the initial rise in glucose after VMH stimulation but impaired the response at 10 and 15 min. As mentioned above, the plasma glucagon level was elevated by VMH stimulation. Nevertheless, prior injection of antiglucagon serum impaired, but did not abolish the early hyperglycaemic response to VMH stimulation, indicating that the role of glucagon in this response was also related to maintenance, rather than initiation, of hyperglycaemia.
It thus seems clear that the hypothalamus has a dual mechanism of control of liver glycogen metabolism and glucose homeostasis: one mechanism is by direct neural innervation of the liver, via the VMHsplanchnic nerve and the LH-vagus nerve pathways, which directly controls the enzymes metabolizing glycogen in the liver and thus is responsible for the initial and fine regulation of metabolic changes. The other mechanism is the neural-hormonal regulation of glycogen breakdown and synthesis described above, which is responsible for prolongation or consolidation of metabolic changes rather than for their initiation.
Hypothalamo-Hepatic Relation in the Control of Amino Acid Metabofism
The diencephalon has been suspected for many years to house a "protein metabolism centre". The involvement of the hypothalamus in regulation of amino acid metabolism was suggested in our early studies [60, 61] on the effects of electrical stimulation of the VMH and LH upon tryptophan pyrrolase (EC 1.13.1.12), an enzyme catalyzing the first step of tryptophan metabolism in the liver. Stimulation of the VMH or LH both markedly increased the activity of this enzyme, but their effects were different: stimulation of the VMH resulted in more than a 3-fold increase in the total activity of enzyme and about half the enzyme was saturated with respect to its cofactor (ironporphyrin), in vivo; stimulation of the LH also resulted in about a 3-fold increase in total enzyme activity, but only one-fifth of the enzyme was combined with cofactor. Thus, more apo-enzyme protein would be accumulated on LH stimulation than on VMH stimulation. Since this enzyme is known to be induced by cortisone administration, the observed effects might have been due to a hypothalamo-neuroendocrine effect on the adrenal. However, bilateral adrenalectomy did not abolish the effects of electrical stimulation of the VMH and LH [61] , indicating significant involvement of other hypothalamo-autonomic nerves in enzyme regulation.
Black and Reis [62] showed that electrical stimulation of the vagus nerves or" administration of carbachol in adrenalectomized rats induces the activity of liver tyrosine aminotransferase (EC 2.6.1.5), an enzyme catalyzing the first reaction in the pathway by which tyrosine is finally degraded to acetoacetate and fumarate. As an extension of our previous studies [11] [12] [13] [14] on chemical coding of the hypothalamic neurones in metabolic control, we have investigated the hypothalamic control of this hepatic enzyme by selectively stimulating the LH, a presumed parasympathetic centre [2, 5, 6] , with different neurotransmitters. The results are shown in Figure 5 . Cholinergic stimulation of the LH by local application of acetylcholine greatly increased (about 3.5-fold) the enzyme activity over 4 h, as compared with that in control rats similarly treated with saline. However, similar application of other neurotransmitters, such as dopamine, norepinephrine, serotonin, GABA, histamine, and glutamic acid, did not affect the enzyme activity.
The effect of cholinergic stimulation of the LH on liver tyrosine aminotransferase was blocked completely by previous intrahypothalamic injection of atropine (Fig. 6, Expt. 1 ), indicating that acetylcholine-sensitive neurones of the LH are specifically involved in regulation of this hepatic enzyme, as in the case of liver glycogen synthetase [11, 12] . The response of tyrosine aminotransferase to cholinergic stimulation of the LH was also suppressed by previous and additional IP injections of the peripheral cholinolytic agent, N-methylatropine (Fig. 6, Expt. 2), or by bilateral subdiaphragmatic vagotomy (Fig. 6, Expt. 3) . These results suggest that the hypothalamic cholinergic influence on liver tyrosine aminotransferase is mediated largely by the cholinergic system in the LH-vagal pathway. Our results are consistent with the view of Black and Reis [62] that the vagal-cholinergic nerves are concerned in neural regulation of liver tyrosine aminotransferase.
i Hypothalamic Regulation of Lipid Metabolism in Adipose Tissue
It has been well established that the hypothalamus is implicated in the development of obesity in experimental animals. The syndrome of hypothalamic obesity results from destruction of the ventromedial region of the hypothalamus, and accordingly, hypothalamic influences upon lipid metabolism have been directed chiefly at understanding the mechanisms underlying development of obesity after injuring the VMH. Recent advances in this field have been reviewed [63, 64] .
At least 3 main factors contribute to genesis of this syndrome: a) Hyperphagia due to damage to the ventromedial hypothalamic "satiety centre". Ablation of this satiety centre is believed to remove the inhibitory influences of a primary feeding centre in the lateral hypothalamus and allow excess feeding [3] . The resulting excess nutrients are deposited as body fat. b) Hyperinsulinaemia chronically induced by VMH lesions. Increased secretion of insulin can stimulate lipogenesis in adipose tissue, resulting in obesity, c) Possible derangement in the autonomic nervous system after destruction of the VMH. Since the VMH is part of the hypothalamic component of the sympathetic nervous system, its destruction may lead to decrease in sympathetic activity or, alternatively, increase in parasympathetic tone, which would favor reduced lipolysis and enhanced lipogenesis. Early studies on the mechanism of the syndrome of hypothalamic obesity stressed hyperphagia as a primary factor, while hyperinsulinaemia was regarded as a secondary factor resulting from overeating [54] . Subsequent studies in weanling rats 1155] and adult rats that were pair fed to prevent hyperphagia [56, 57] , however, showed that hyperinsulinaemia due to VMH lesions was not a consequence of hyperphagia, but a primary effect, and that obesity developed even in the absence of hyperphagia.
Recently, emphasis has been put on the possible link between hyperinsulinaemia and disturbances in the hypothalamo-autonomic nervous system as an explanation of the etiology of hypothalamic obesity. Inoue et al. [65] have shown that the ]~yperin-sulinaemia following VMH lesions is dependent upon intact neural innervation to the pancreatic Mets and have suggested the prime importance of neural con- nections to the pancreas in the genesis of this type of obesity. They found that VMH lesions in diabetic rats that are cured by transplanting pancreatic tissue beneath the renal capsule do not produce hyperinsulinaemia, or induce hyperphagia and body weight gain. Possibly, the vagus nerves mediate the hyperinsulinaemia in the VMH syndrome, since the vagus nerves are known to stimulate insulin secretion and VMH lesions may increase vagal parasympathetic activity and suppress sympathetic activity. This notion is supported by the finding that rats with VMH lesions show increased-gastric acid secretion and that subdiaphragmatic vagotomy reverses the obesity and hyperinsulinaemia due to VMH lesions [53, 58, 66] . Diminished activity of the sympathetic nervous system may also account for the hyperinsulinaemia characteristic of this syndrome. In the light of these observations, it is most probable that obesity induced by VMH lesions is due to a primary alteration in autonomic nervous regulation of insulin secretion and subsequent stimulation of lipogenesis in adipose tissue. As mentioned, most previous studies on hypothalamic influences upon lipid metabolism have been focused on the reason for obesity after injuring the VMH; there have been few studies on changes of lipolysis and lipogenesis in adipose tissue after stimulating the VMH and LH. Our previous studies [67] showed that electrical stimulation of the VMH caused lipolysis in rabbits, detected by a marked increase in plasma glycerol concentration, whereas electrical stimulation of the LH had no effect on lipolysis. In these experiments, however, electrical stimulation of the VMH in unanaesthetized rabbits was not associated with an increase in the concentration of plasma free fatty acids (FFA), another hydrolytic product of triglycerides, in spite of a marked elevation of plasma glycerol. Second, approximately 80% of the plasma glycerol elevation elicited by VMH stimulation was eliminated by bilateral adrenalectomy, suggesting that the adrenal medulla was principally involved in VMH-induced lipolysis and that sympathetic innervation of the adipose tissue was subdominant in this species [67, 68] .
We have reexamined hypothalamic regulation of lipolysis by using unanaesthetized and anaesthetized rats. In unanaesthetized rats, electrical stimulation of the VMH caused a marked increase in the concentration of plasma glycerol, but did not increase the plasma FFA concentration, confirming the previous observation in rabbits. The absence of an increase of plasma FFA in unanaesthetized animals can be attributed to either a large elevation of plasma lactate, which inhibits the release of FFA from adipose tissue by increasing the rate of reesterification, or to increased FFA utilization in muscle, since electrical stimulation of the VMH in unanaesthetized animals elicits excitement and muscular activity. In anaesthetized rats, stimulation of the VMH caused no increase in plasma lactate, and the plasma glycerol and FFA concentrations were both elevated markedly (Fig. 7) . Again, electrical stimulation of the LH had no significant effect on plasma glycerol and FFA concentrations. Also, as shown in Figure 7 , bilateral adrenodemedullation did not prevent the lipolytic response to VMH stimulation, although it reduced slightly the increment of plasma glycerol and FFA. However, the lipolytic response was completely blocked by previous treatment of the animals with hexamethonium or propranolol, but not with phentolamine. These results suggest that sympathetic innervation of the adipose tissue is the dominant factor involved in VMH-induced lipolysis, while the role of the adrenal medulla is subdominant in the rat; the effect of VMH stimulation is mainly transmitted through the sympathetic nerves to fl-adrenergic receptor of the adipose tissue.
Our results are consistent with the concept that the ventromedial region of the hypothalamus acts as a regulatory centre for fat mobilization by modulating activation of the sympathetic nervous system. This concept was confirmed by the recent findings of Bray and Nishizawa [69, 70] that both VMH lesions and sympathetic denervation in rats attenuated the mobilization of FFA and glycerol from the adipose tissue caused by stimuli that involve the sympathetic nervous system (such as fasting, forced swimming, exposure to cold, or administration of 2-deoxyglucose), whereas lesions of the LH did not significantly change fat mobilization. This is taken to indicate that VMH lesions impair fat mobilization by reducing sympathetic tone of the fat depots, and that the obesity which follows bilateral VMH lesions may be in part due to this reduced sympathetic activity and the resulting reduction in lipolysis.
There is ample evidence that the sympathetic nervous system participates in the regulation of lipolysis. Adipose tissue is richly supplied by sympathetic nerve fibres, which are important in control of its metabolic activity, and the norepinephrine released from sympathetic nerve endings is of prime importance for lipolysis in situations requiring increased sympathetic activity, such as during cold exposure, forced muscular activity, or starvation [71] . Also, there is some evidence that direct stimulation of the sympathetic nerves causes fat mobilization from the adipose tissue: electrical stimulation of the sympathetic nerve supply of the epididymal fat pads incubated in vitro results in the rapid release of FFA and glycerol into the incubation medium [72, 73] . Stimulation of the sympathetic nerves to subcutaneous adipose tissue increases the outflow of glycerol and FFA from the tissue perfused in situ, and the effect of nerve stimulation is inhibited by fl-adrenergic blocking agents and potentiated by a-adrenergic blockade [74] .
It is unknown whether hypothalamic stimulation of either the VMH or the LH affects lipogenesis in adipose tissue. We have investigated this problem by measuring the incorporation of radioactivity from 14C-glucose into fatty acids and glycerol moieties of triglycerides, in vivo. Surprisingly, on electrical stimulation of the VMH, the rate of triglyceride synthesis measured by this method increased markedly in the brown (interscapular) adipose tissue and decreased significantly in the liver, but did not change in the white (parametrial and retroperitoneal) adipose tissue of rats. Electrical stimulation of the LH, however, did not discernibly alter the rate of triglyceride synthesis in any of the three tissues. synthesis in streptozotocin-induced diabetic rats. The VMH of rats, previously made diabetic by IV injection of streptozotocin (65 mg/kg), was stimulated electrically for 30-s periods once every minute for 10 rain, and then the rats were injected IP with 3 mCi of 3H20 in 0.3 ml of 0.154 mol/l saline. After another 30-rain period of intermittent stimulation, they were killed and the interscapular, retroperitoneal and parametrial adipose tissues and the liver were removed and frozen rapidly. Total lipids from each tissue were hydrolyzed, and after extraction of the fatty acids, the radioactivity was measured. The rate of fatty acid synthesis was calculated from the radioactivity in fatty acids and in the plasma obtained at the time of death. Columns and bars are means and SEM of values in 8 animals
For confirmation of these findings we repeated the experiments using 3H20 as a radioactive precursor and measured the incorporation of tritium into fatty acids of triglycerides [75] . This latter technique is the most reliable method for measuring the rate of fatty acid biosynthesis because it is independent of the carbon precursor. The rate of fatty acid synthesis in control rats was about 4 times greater in brown adipose tissue than in white adipose tissue. With electrical stimulation of the VMH, the rate increased more (about 2.3 times that of unstimulated ,controls) in the interscapular adipose tissue, but not in the parametrial and retroperitoneal adipose tissues. Again, electrical stimulation of the LH did not appreciably affect lipid synthesis in either type of adipose tissue.
Enhanced lipid synthesis in brown adipose tissue upon VMH stimulation was also observed in rats previously made diabetic by streptozotocin-treatment ( Fig. 8) : the rate of fatty acid synthesis in the two types of adipose tissue and in the liver of diabetic control rats was reduced to below half the values in healthy control rats, possibly owing to lack of the lipogenic action of insulin. Nonetheless, electrical stimulation of the VMH of the diabetic rats markedly increased the rate in interscapular brown adipose tissue. There was no significant increase in the lipogenic response in either retroperitoneal or parametrial white adipose tissue, and conversely fatty acid synthesis in the liver decreased slightly, though not significantly, with stimulation of the VMH.
These results indicate that stimulation of the VMH enhances lipogenesis in brown adipose tissue preferentially, through a mechanism not involving insulin. This effect is probably mediated by sympathetic innervation of brown adipose tissue, because the VMH is presumed to be part of the sympathetic neural output from the hypothalamus. Brown adipose tissue, which is found in specific anatomical locations such as the interscapular area, the mediastinum, and along the aorta and vertebral column, has abundant sympathetic innervation with adrenergic fibres which form nest-like networks around every fat cell. On the other hand, white adipose tissue contains no adrenergic fibres except those related to the blood vessels, and consequently its norepinephrine content is much lower than that of brown adipose tissue [76] . Therefore, norepinephrine may be a mediator of the effect of VMH stimulation on lipogenesis in brown adipose tissue. However, it is also possible that some lipogenic factor(s) released from the hypothalamus acts on brown fat cells; such a factor has recently been suggested to be present in an extract of bovine hypothalamus [77] .
Our results, together with the observation of increased lipolysis in adipose tissue after VMH stimulation, suggest that both the breakdown and resynthesis, i.e., the turnover, of triglycerides in brown adipose tissue, but not in white adipose tissue, are accelerated by stimulation of the VMH. Since brown adipose tissue is an important fat depot for physiological lipolysis mediated by the sympathetic nerves, especially during cold acclimatization, this could also explain the increased lipid turnover in the brown adipose tissue of cold-acclimatized animals [78] . Although electrical stimulation of the LH fails to alter lipid synthesis in white adipose tissue, it cannot exclude a possible implication of the LH in control of lipogenesis; for neuronal organization of the LH is complex, its electrical stimulation may mask the actual effect. Further investigations are needed to explore this possibility by selective stimulation of neurones in the LH.
